XML 42 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1
Equity (Tables)
 12 Months Ended
Dec. 31, 2023
Stockholders' Equity Note [Abstract]  
Schedule of Common Stock Shares Reserved For Future Issuance
Shares of authorized but unissued common stock reserved for future issuance were as follows (in thousands):
 December 31, 2023December 31, 2022
Stock options issued and outstanding218 226 
Restricted stock units issued and outstanding3,105 2,238 
Performance-based stock units issued and outstanding400 242 
Shares available for grant2,810 5,165 
Total shares reserved6,533 7,871 
Schedule of Stock Option Share Activity Under Stock Plans
The following table summarizes activity under our A&R 2014 Plan and A&R 2021 Inducement Plan for the year ended December 31, 2023 (in thousands):

Balance at December 31, 2022(1)
5,165 
Restricted stock units granted(2,413)
Performance-based stock units granted(337)
Restricted stock units cancelled283 
Performance-based stock units cancelled104 
Options cancelled8 
Balance at December 31, 20232,810 
_______ 
(1)Shares available for grant do not include treasury stock shares that could be granted if we determined to do so.
Schedule of Stock-Based Compensation Expense By Award Type The following table summarizes stock-based compensation expense recognized for the years presented below (in thousands):
Year Ended December 31,
202320222021
Restricted stock units$19,151 $17,837 $23,645 
Performance-based stock units2,422 876 6,867 
Common stock options1,254 1,154 707 
Employee stock purchase program386 449 1,638 
Total stock-based compensation expense$23,213 $20,316 $32,857 
Related tax benefit recognized$5,488 $4,747 $7,746 
Schedule of Stock-Based Compensation Expense By Operating Function
The following table summarizes stock-based compensation expense by operating function for the years presented below (in thousands):
 Year Ended December 31,
 202320222021
Marketing and advertising$2,201 $1,901 $8,660 
Customer care and enrollment2,287 2,096 2,836 
Technology and content4,498 6,015 10,013 
General and administrative14,227 10,304 11,348 
Total stock-based compensation expense23,213 20,316 32,857 
Amount capitalized for internal-use software1,040 1,885 2,621 
Total stock-based compensation$24,253 $22,201 $35,478 
Schedule of Activity Under Stock Plans The following table summarizes stock option activity (in thousands, except weighted-average exercise price and weighted-average remaining contractual life data):
 
Number of Stock Options (1)
Weighted Average Exercise PriceWeighted-Average Remaining Contractual Life (years)
Aggregate Intrinsic Value (2)
Outstanding as of December 31, 2022226 $39.07 5.3$— 
Granted— $— 
Exercised— 
Forfeited(8)$23.34 
Outstanding balance as of December 31, 2023218 $39.65 4.5$— 
Vested and expected to vest as of December 31, 2023194 $39.48 4.5$— 
Exercisable as of December 31, 202374 $36.98 4.0$— 
_______ 

(1)Includes certain stock options with service, performance-based or market-based vesting criteria.
(2)The aggregate intrinsic value is calculated as the product between eHealth’s closing stock price as of December 31, 2023 and 2022 and the exercise price of in-the-money options as of those dates. 

The following table provides information pertaining to our stock options for the years presented below (in thousands, except weighted-average fair values):
 Year Ended December 31,
 202320222021
Weighted average fair value of options granted n/a n/a$41.03 
Total fair value of options vested$534 $835 $797 
Intrinsic value of options exercisedn/a$694 $5,182 
Schedule of Fair Value Of Stock Options Granted, Valuation Assumptions For the options granted during the year ended December 31, 2021, the fair value of stock options granted to employees was estimated using the Black-Scholes option-pricing model and with the following weighted average assumptions for the year presented below:
 Year Ended December 31,
 2021
Expected term (years)7.0
Expected volatility69.1%
Expected dividend yield—%
Risk-free interest rate1.3%
Schedule of Restricted Stock Unit Activity Under Stock Plans The following table summarizes restricted stock unit activity (in thousands, except weighted-average grant date fair value and weighted-average remaining service period data):
Number of Restricted Stock Units
Weighted-Average Grant Date Fair Value
Weighted-Average Remaining Service Period (years)
Aggregate Intrinsic Value (1)
Outstanding as of December 31, 20222,238 $19.13 1.4$10,832 
Granted2,413 $8.33 
Vested(1,263)$16.88 
Forfeited(283)$22.80 
Outstanding as of December 31, 20233,105 $11.31 1.3$27,083 
_______
(1)The aggregate intrinsic value is calculated as the difference of the grant date price and our closing stock price as of December 31, 2023 and 2022 multiplied by the number of restricted stock units outstanding as of December 31, 2023 and 2022, respectively.
Schedule of Performance-Based Stock Units The following table summarizes performance-based stock unit activity (in thousands, except weighted-average grant date fair value and weighted-average remaining service period data):
Number of Performance-based Stock Units
Weighted-Average Grant Date Fair Value
Weighted-Average Remaining Service Period (years)
Aggregate Intrinsic Value (1)
Outstanding as of December 31, 2022242 $20.55 1.1$1,172 
Granted337 $7.56 
Vested(75)$4.42 
Forfeited(104)$14.08 
Outstanding as of December 31, 2023400 $14.32 0.6$3,486 
_______
(1)The aggregate intrinsic value is calculated as the difference of the grant date price and our closing stock price as of December 31, 2023 and 2022 multiplied by the number of performance stock units outstanding as of December 31, 2023 and 2022, respectively.
Schedule of Restricted Stock Units, Valuation Assumptions
The weighted-average fair value of the market-based restricted stock units was determined using the Monte Carlo simulation model using the following weighted average assumptions:
Year Ended December 31,
 202320222021
Expected term (years)1.12.12.0
Expected volatility76.3%68.7%66.0%
Expected dividend yield—%—%—%
Risk-free interest rate4.0%2.5%0.9%
Weighted-average grant date fair value$4.79$9.66$46.36